GG

Guro Gafvelin

Chief Technology Officer

NEOGAP Therapeutics AB

Stockholm, Stockholm County


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
NEOGAP Therapeutics AB
Industry
pharmaceuticals
Employees
27.0
Seniority
C suite
Total Funding
472984.0
Latest Funding
Other

Technologies

Outlook Microsoft Office 365 WordPress.org Cision Vimeo Google Tag Manager Google Font API Mobile Friendly Circle Node.js Data Analytics Remote IoT Basis Android AI

Keywords

biopharmaceutical company immunotherapy immunooncology pharmaceutical manufacturing personalised cancer therapy immuno-oncology cell therapy t cell therapy epitcer technology pior technology neoantigen targeting clinical trial tumor-trained lymphocytes advanced cancer treatments cancer immunotherapy tumor-specific mutations biopharmaceutical innovation patient-centric therapies cancer therapeutic solutions bioreactor manufacturing precision medicine pharmaceutical development machine learning in oncology tumor profiling personalised immunotherapy cancer research collaboration cancer patient outcomes colorectal cancer treatment biotech partnerships oncology advancements clinical stage therapy novel therapeutic approaches cancer diagnostics immune response enhancement regulatory compliance in biotechnology safety & tolerability studies cancer cell targeting disease-modifying therapies cancer mutation analysis therapeutic antibody development biotech investment opportunities drug development pipeline clinical study management expert oncology team scientific research in immunology multidisciplinary health solutions neoantigen production tumor microenvironment therapeutic biomarker identification therapeutic innovation strategy global cancer therapeutics market pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans